L Kristin Newby Selected Research

Thrombosis (Thrombus)

11/2008	ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention.
5/2007	Present and evolving role of eptifibatide in the treatment of acute coronary syndromes.
9/2006	Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group.
3/2005	Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials).
8/2003	Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Kristin Newby Research Topics

Disease

96	Acute Coronary Syndrome 01/2023 - 06/2002
63	Myocardial Infarction 09/2023 - 02/2002
32	Hemorrhage 03/2024 - 12/2003
23	Heart Failure 01/2023 - 06/2002
22	Stroke (Strokes) 03/2024 - 11/2002
22	ST Elevation Myocardial Infarction 01/2021 - 06/2004
19	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 06/2002
17	Coronary Artery Disease (Coronary Atherosclerosis) 11/2016 - 06/2002
13	Coronary Disease (Coronary Heart Disease) 01/2023 - 07/2002
13	Unstable Angina 12/2010 - 06/2003
10	Non-ST Elevated Myocardial Infarction 12/2021 - 05/2005
9	Chest Pain (Chest Pains) 09/2023 - 04/2003
9	Inflammation (Inflammations) 10/2019 - 07/2003
8	Atrial Fibrillation 03/2024 - 06/2006
8	Ischemia 03/2017 - 02/2002
7	Diabetes Mellitus 02/2021 - 06/2002
7	Hypertension (High Blood Pressure) 10/2019 - 12/2003
6	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023 - 10/2004
5	Shock 10/2022 - 11/2012
5	Necrosis 07/2012 - 04/2005
5	Thrombosis (Thrombus) 11/2008 - 08/2003
4	Infarction (Infarctions) 09/2013 - 04/2009
3	Iron Deficiencies 01/2023 - 04/2010
3	Renal Insufficiency (Renal Failure) 01/2022 - 07/2005
3	Infections 01/2022 - 07/2012
3	Chronic Renal Insufficiency 03/2015 - 03/2008
3	Atherosclerosis 11/2008 - 07/2003
2	Cardiogenic Shock 04/2024 - 02/2012
2	COVID-19 10/2023 - 01/2022
2	Dementia (Dementias) 01/2023 - 01/2023
2	Idiopathic Pulmonary Fibrosis 03/2020 - 10/2019
2	Virus Diseases (Viral Diseases) 01/2020 - 01/2015
2	Hyperlipidemias (Hyperlipidemia) 01/2016 - 01/2013
2	Heart Diseases (Heart Disease) 11/2015 - 07/2006
2	Insulin Resistance 01/2014 - 07/2013
2	Coronary Stenosis (Coronary Artery Stenosis) 07/2011 - 07/2005

Drug/Important Bio-Agent (IBA)

31	Biomarkers (Surrogate Marker)IBA 01/2024 - 07/2002
29	TroponinIBA 01/2021 - 02/2003
23	Glycoproteins (Glycoprotein)IBA 01/2020 - 06/2002
21	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2024 - 06/2002
18	Eptifibatide (Integrilin)FDA Link 04/2014 - 06/2003
9	Clopidogrel (Plavix)FDA Link 01/2021 - 04/2006
8	MB Form Creatine KinaseIBA 09/2017 - 04/2003
8	paragonIBA 12/2010 - 02/2002
8	sibrafibanIBA 08/2007 - 06/2002
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 06/2002
6	trans-crotonin (CTN)IBA 01/2023 - 03/2008
6	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 12/2007
6	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 12/2003
6	CreatinineIBA 01/2018 - 06/2002
5	Troponin T (Troponin T1)IBA 03/2017 - 06/2002
5	Warfarin (Coumadin)FDA LinkGeneric 04/2014 - 02/2010
5	Heparin (Liquaemin)FDA LinkGeneric 12/2011 - 08/2002
5	Platelet Membrane Glycoprotein IIbIBA 11/2011 - 09/2006
4	SodiumIBA 01/2022 - 01/2008
4	Hemoglobins (Hemoglobin)IBA 02/2021 - 06/2013
4	Troponin IIBA 09/2017 - 04/2003
4	CytokinesIBA 02/2016 - 10/2008
4	Enoxaparin (Lovenox)FDA LinkGeneric 07/2013 - 03/2008
3	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2023 - 09/2016
3	Interleukin-6 (Interleukin 6)IBA 02/2015 - 12/2003
3	Complement System Proteins (Complement)IBA 09/2013 - 07/2005
3	AnticoagulantsIBA 03/2013 - 11/2005
3	Ranolazine FDA Link 01/2011 - 04/2007
3	Creatine Kinase (Creatine Phosphokinase)IBA 11/2009 - 04/2003
3	Platelet Membrane GlycoproteinsIBA 02/2008 - 06/2003
3	Hormones (Hormone)IBA 09/2006 - 07/2002
2	apixabanIBA 03/2024 - 11/2010
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 12/2019
2	Metformin (Glucophage)FDA LinkGeneric 02/2021 - 08/2013
2	TicagrelorIBA 01/2021 - 01/2020
2	LipidsIBA 12/2020 - 01/2006
2	Branched-Chain Amino AcidsIBA 12/2020 - 01/2014
2	Prasugrel Hydrochloride FDA Link 01/2020 - 04/2017
2	CalciumIBA 10/2019 - 01/2008
2	MyoglobinIBA 09/2017 - 04/2003
2	Abciximab (ReoPro)FDA Link 01/2016 - 03/2005
2	RNA (Ribonucleic Acid)IBA 01/2015 - 11/2005
2	6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA 09/2014 - 11/2012
2	p38 Mitogen-Activated Protein KinasesIBA 09/2014 - 11/2012
2	pro-brain natriuretic peptide (1-76)IBA 10/2013 - 07/2012
2	Streptokinase FDA Link 09/2013 - 12/2007
2	Tissue Plasminogen Activator (Alteplase)FDA Link 09/2013 - 12/2007
2	Triglycerides (Triacylglycerol)IBA 07/2013 - 12/2003
2	oxidized low density lipoproteinIBA 01/2013 - 09/2009
2	LDL CholesterolIBA 01/2013 - 09/2009
2	Antihypertensive Agents (Antihypertensives)IBA 01/2012 - 12/2005
2	DNA (Deoxyribonucleic Acid)IBA 07/2011 - 11/2005

Therapy/Procedure

52	Therapeutics 09/2023 - 06/2002
30	Percutaneous Coronary Intervention 01/2022 - 07/2003
13	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2022 - 09/2004
10	Critical Care (Surgical Intensive Care) 04/2024 - 11/2002
7	Secondary Prevention 04/2015 - 06/2002
5	Length of Stay 12/2021 - 02/2004
4	Blood Transfusion (Blood Transfusions) 07/2013 - 10/2004
3	Erythrocyte Transfusion 04/2013 - 03/2005
2	Induced Hypothermia 01/2023 - 02/2012
2	Drug Therapy (Chemotherapy) 03/2015 - 07/2011
2	Medication Errors (Medication Error) 04/2010 - 11/2002
2	Contraindications 10/2009 - 05/2007